Keywords: Novartis, Biotechnology production facility, Singapore, Investment

Novartis to invest $500 million in new Singapore biotechnology facility

Article | 01 November 2012

Swiss drug major Novartis (NOVN: VX) says it plans to invest over $500 million in the construction of a new state-of-the-art ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in